Tools4Patient Develops Predictive Model of the Placebo Response in Parkinson’s Disease

September 17, 2021

Tools4Patient presented data at the MDS Congress 2021 that predicted the placebo response in Parkinson’s disease (PD) in a multi-center, multi-national clinical study.

Read More

“Understanding Placebo Response and Patient Personality” Outsourcing-Pharma Article

August 10, 2021

A representative from Tools4Patient discusses how grasping the ties between the two can help in reducing the impact of the placebo response in trials.

Read More

Open Position: Data Mining and Statistical Research Specialist

June 14, 2021

Tools4Patient is actively looking for a Junior/Senior Data Mining and Statistical Research Specialist. Look at our open position and stay tune.

Read More

Tools4Patient Proves Performance of Novel Technology to Predict Placebo Response in Osteoarthritis Clinical Trials

May 3, 2021

Belgian startup Tools4Patient recently presented data showing its novel technology Placebell©™ predicted placebo response in a Phase 2 randomized controlled trial (RCT) for osteoarthritis (OA). Placebell is the first robust technology using predictive modeling that is proven to reduce the impact of the placebo response in clinical trials under real-world conditions. Data from the Phase 2 RCT, “Predicting the Placebo Response in OA to Improve the Precision of the Treatment Effect Estimation,” was presented as a late-breaking abstract at the OARSI Connect Virtual World Congress on Osteoarthritis on April 29, 2021. This innovation by Tools4Patient is a major advancement for increasing clinical study success and reducing drug development costs and timelines.

Read More

Tools4Patient Adds Quality Assurance Director To Team

April 2, 2021

The addition of Delphine to T4P’s expanding team reflects the company’s commitment to building and maintaining a robust quality program, which is central to its goal of being a trusted partner providing predictive tools to biopharmaceutical companies. Delphine works with T4P’s operational and scientific groups to support software and clinical-related activities for programs conducted with sponsors or as part of the company’s R&D activities.

Read More

Webinar: Predict placebo response using patient psychology to increase trial power

March 3, 2021

What if you could predict placebo responsiveness of each patient in your clinical trial? Historical strategies to address the placebo response may help but haven’t completely solved the placebo response problem. Until now. Advanced methods like AI and machine learning are uniquely poised to help scientists uncover the full spectrum of patient placebo responsiveness in a clinical trial. Learn more about this approach by attending our webinar, which explains how a solution like Placebell©™ leverages a time-tested predictive algorithm to improve clinical trial assay sensitivity and de-risk drug development.

Read More

Happy Holidays from our home offices to yours

December 15, 2020

With 2020 coming to a close, it is an opportune time to pause and reflect on the progress we have made as an industry, as a company and as individuals. We congratulate our partners and friends for their ingenuity and perseverance in rising to the challenges of the year.

Read More

“Stratification of patients based on the neuropathic pain symptom inventory (NPSI): development and validation of a new algorithm” published in Pain.

November 18, 2020

The journal article “Stratification of patients based on the neuropathic pain symptom inventory (NPSI): development and validation of a new algorithm”, has been published ahead of print in the journal Pain. This article was authored by Didier Bouhassira, MD, Director of Research at the National Institute for Health and Medical Research (INSERM) in France and member of Tools4Patient’s scientific advisory board, and was co-authored by Tools4Patient scientists Samuel Branders PhD, Alvaro Pereira PhD and Dominique Demolle, PhD.

Read More

The Placebo Response: A Hidden Risk to COVID-19 Trials” – First Opinion written by Tools4Patient authors published in STAT News

October 20, 2020

STAT News published “The Placebo Response: A Hidden Risk to COVID-19 Trials” written by Tools4Patient authors on October 13, 2020. The article, authored by Erica Smith PhD, VP of Business Development and Dominique Demolle PhD, CEO, was published in STAT’s First Opinion column. The article asserts that the success of the abundant drug development program for COVID-19 therapies

Read More

Tools4Patient expands into new office space

September 24, 2020

The Tools4Patient team has moved our offices to a new building located in the same scientific campus in Louvain-La-Neuve, Belgium in early September, 2020. The rapid expansion of collaborations with innovative biopharma companies has led to 30% growth of our team – particularly in scientific and operational support areas – over the last year.

Read More